Moreover, treatment of those mice with blocking antibodies to either PD1 or CD25 abrogated colitis resistance observed in mice with Smad7-deficient DCs, supporting the contribution of Tregs and Treg-promoting PD1 signaling in mitigating colitis severity in mice carrying on Smad7-deficient DCs. Here, SMAD7 is linked to colitis.